Evidence map›Paper›PMID 34324772›Full record

ArticlePediatric diabetes2021

Youth and parent preferences for an ideal AP system: It is all about reducing burden.

Persis V Commissariat, Lindsay C Roethke, Jennifer L Finnegan, Zijing Guo, Lisa K Volkening, Deborah A Butler, Eyal Dassau, Stuart A Weinzimer, Lori M Laffel

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Pediatric diabetes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03534544 (Patient and Parent Preferences for an On-Body Automated Insulin Delivery System), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03534544 completednot on this map

Patient and Parent Preferences for an On-Body Automated Insulin Delivery System

TypeobservationalSponsorJoslin Diabetes CenterRan2018 to 2019Enrolled362ConditionsDiabetes Mellitus, Type 1
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Persis V CommissariatSection on Clinical, Behavioral, and Outcomes Research, Joslin Diabetes Center, Boston, Massachusetts, USA.ORCID 0000-0002-6964-1223
Lindsay C RoethkeSection on Clinical, Behavioral, and Outcomes Research, Joslin Diabetes Center, Boston, Massachusetts, USA.
Jennifer L FinneganDepartment of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
Zijing GuoSection on Clinical, Behavioral, and Outcomes Research, Joslin Diabetes Center, Boston, Massachusetts, USA.
Lisa K VolkeningSection on Clinical, Behavioral, and Outcomes Research, Joslin Diabetes Center, Boston, Massachusetts, USA.ORCID 0000-0002-8749-743X
Deborah A ButlerSection on Clinical, Behavioral, and Outcomes Research, Joslin Diabetes Center, Boston, Massachusetts, USA.ORCID 0000-0002-8469-4673
Eyal DassauSection on Clinical, Behavioral, and Outcomes Research, Joslin Diabetes Center, Boston, Massachusetts, USA.ORCID 0000-0001-5333-6892
Stuart A WeinzimerDepartment of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0002-7768-5189
Lori M LaffelSection on Clinical, Behavioral, and Outcomes Research, Joslin Diabetes Center, Boston, Massachusetts, USA.ORCID 0000-0002-9675-3001
Joslin Diabetes Center · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
TRAINING IN DIABETES AND METABOLISMT32DK007260 · NIDDK · JOSLIN DIABETES CENTER · PI LAURIE J GOODYEAR · 1986 to 2026
$13.6M
CAREER DEVELOPMENT IN DIABETES RESEARCH FOR PEDIATRIC ENDOCRINOLOGISTSK12DK094721 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI LAFFEL, LORI M, WHITE, MORRIS F. · 2011 to 2021
$6.3M
On-body ecosystem for automated insulin delivery in type 1 diabetesDP3DK113511 · NIDDK · YALE UNIVERSITY · PI DASSAU, EYAL, LAFFEL, LORI M · 2017 to 2017
$3.0M
Pediatric Artificial Pancreas System for Enhanced Diabetes Management in Young Children with Type 1 DiabetesDP3DK104057 · NIDDK · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI DASSAU, EYAL, DOYLE, FRANCIS J · 2014 to 2014
$1.8M
NCATS NIH HHS UL1 TR001863NIDDK NIH HHS DP3 DK104057NIDDK NIH HHS DP3 DK113511NIDDK NIH HHS K12 DK094721NIDDK NIH HHS P30 DK036836NIDDK NIH HHS T32 DK007260
6 · The paper itself

Abstract

backgroundAs new diabetes technologies improve to better manage glucose levels, users' priorities for future technologies may shift to prioritize burden reduction and ease of use. We used qualitative methods to explore youth and parent desired features of an "ideal" artificial pancreas (AP) system.

methodsWe conducted semi-structured interviews with 39 youth, ages 10-25 years, and 44 parents. Interviews were audio-recorded, transcribed, and coded using thematic analysis.

resultsYouth (79% female, 82% non-Hispanic white) were (M ± SD) ages 17.0 ± 4.7 years, with diabetes for 9.4 ± 4.9 years, and HbA1c of 8.4 ± 1.1%; 79% were pump-treated and 82% used CGM. Of parents, 91% were mothers and 86% were non-Hispanic white. Participants suggested various ways in which an ideal AP system could reduce physical and emotional burdens of diabetes. Physical burdens could be reduced by lessening user responsibilities to manage glucose for food and exercise, and wear or carry devices. Emotional burden could be reduced by mitigating negative emotional reactions to sound and frequency of alerts, while increasing feelings of normalcy. Youth and parents differed in their suggestions to reduce emotional burden. Participants suggested features that would improve glycemia, but nearly always in the context of how the feature would directly reduce their diabetes-specific burden.

conclusionsAlthough participants expressed interest in improving glucose levels, the pervasive desire among suggested features of an ideal AP system was to minimize the burden of diabetes. Understanding and addressing users' priorities to reduce physical and emotional burden will be necessary to enhance uptake and maintain use of future AP systems.

Indexed as

Cost of IllnessPancreas, ArtificialParentsAdolescentChildDiabetes Mellitus, Type 1EmotionsFemaleGlycated HemoglobinGlycemic ControlHumansHypoglycemic AgentsInsulinInsulin Infusion SystemsMalePatient PreferenceGlycated HemoglobinHypoglycemic AgentsInsulinadolescentsartificial pancreasautomated insulin deliveryburdenchildrenparentssystem designtype 1 diabetesyoung adults

Identifiers

PMID34324772
PMCPMC8530854
OpenAlexW3185453116

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.